National Institute of Allergy and Infectious Diseases; Notice of Closed Meeting, 53972 [2021-21133]
Download as PDF
<![CDATA[
53972
Federal Register / Vol. 86, No. 186 / Wednesday, September 29, 2021 / Notices
552b(c)(4) and 552b(c)(6), Title 5 U.S.C.,
as amended. The grant applications and
the discussions could disclose
confidential trade secrets or commercial
property such as patentable material,
and personal information concerning
individuals associated with the grant
applications, the disclosure of which
would constitute a clearly unwarranted
invasion of personal privacy.
Name of Committee: National Center for
Advancing Translational Sciences Special
Emphasis Panel; Conference Grants.
Date: October 27, 2021.
Time: 2:00 p.m. to 4:30 p.m.
Agenda: To review and evaluate grant
applications.
Place: National Center for Advancing
Translational Sciences, National Institutes of
Health 6701 Democracy Boulevard, Room
1037, Bethesda, MD 20892, (Telephone
Conference Call).
Contact Person: M. Lourdes Ponce, Ph.D.,
Scientific Review Officer, Office of Scientific
Review, National Center for Advancing
Translational Sciences, National Institutes of
Health 6701 Democracy Boulevard, Room
1037, Bethesda, MD 20892, 301–435–0810,
lourdes.ponce@nih.gov.
(Catalogue of Federal Domestic Assistance
Program Nos. 93.859, Pharmacology,
Physiology, and Biological Chemistry
Research; 93.350, B—Cooperative
Agreements; 93.859, Biomedical Research
and Research Training, National Institutes of
Health, HHS)
Dated: September 23, 2021.
David W. Freeman,
Program Analyst, Office of Federal Advisory
Committee Policy.
Name of Committee: National Institute of
Allergy and Infectious Diseases Special
Emphasis Panel; NIAID Investigator Initiated
Program Project Applications (P01 Clinical
Trial Not Allowed).
Date: October 22, 2021.
Time: 11:00 a.m. to 5:00 p.m.
Agenda: To review and evaluate grant
applications.
Place: National Institute of Allergy and
Infectious Diseases, National Institutes of
Health, 5601 Fishers Lane, Room 3G56,
Rockville, MD 20892 (Virtual Meeting).
Contact Person: Poonam Tewary, Ph.D.,
Scientific Review Officer, Scientific Review
Program, Division of Extramural Activities,
National Institute of Allergy and Infectious
Diseases, National Institutes of Health, 5601
Fishers Lane, Room 3G56, Rockville, MD
20852, (301) 761–7219, tewaryp@
mail.nih.gov.
(Catalogue of Federal Domestic Assistance
Program Nos. 93.855, Allergy, Immunology,
and Transplantation Research; 93.856,
Microbiology and Infectious Diseases
Research, National Institutes of Health, HHS)
Dated: September 23, 2021.
Tyeshia M. Roberson-Curtis,
Program Analyst, Office of Federal Advisory
Committee Policy.
[FR Doc. 2021–21133 Filed 9–28–21; 8:45 am]
BILLING CODE 4140–01–P
DEPARTMENT OF HOMELAND
SECURITY
Coast Guard
[Docket No. USCG–2010–0164]
National Boating Safety Advisory
Committee; Oct 2021 Teleconference
[FR Doc. 2021–21125 Filed 9–28–21; 8:45 am]
BILLING CODE 4140–01–P
U.S. Coast Guard, Department
of Homeland Security.
ACTION: Notice of Federal Advisory
Committee teleconference meeting.
AGENCY:
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
National Institutes of Health
lotter on DSK11XQN23PROD with NOTICES1
Pursuant to section 10(d) of the
Federal Advisory Committee Act, as
amended, notice is hereby given of the
following meeting.
The meeting will be closed to the
public in accordance with the
provisions set forth in sections
552b(c)(4) and 552b(c)(6), Title 5 U.S.C.,
as amended. The grant applications and
the discussions could disclose
confidential trade secrets or commercial
property such as patentable material,
and personal information concerning
individuals associated with the grant
applications, the disclosure of which
would constitute a clearly unwarranted
invasion of personal privacy.
VerDate Sep<11>2014
18:22 Sep 28, 2021
The National Boating Safety
Advisory Committee (Committee) and
its subcommittees will meet via
teleconference to discuss matters
relating to recreational boating safety.
The meeting will be open to the public.
DATES:
Meeting: The National Boating Safety
Advisory Committee will meet by
teleconference on Thursday, October 21,
2021 from 12:00 p.m. until 4:30 p.m.,
(Eastern Daylight Time). The
teleconference may adjourn early if the
Committee has completed its business.
Comments and supporting
documentation: To ensure your
comments are received by Committee
members before the teleconference,
submit your written comments no later
than October 14, 2021.
ADDRESSES: To join the teleconference
or to request special accommodations,
SUMMARY:
National Institute of Allergy and
Infectious Diseases; Notice of Closed
Meeting
Jkt 253001
PO 00000
Frm 00031
Fmt 4703
Sfmt 4703
contact the individual listed in the FOR
section
no later than 1 p.m. on October 19,
2021, to obtain the needed information.
The number of teleconference lines are
limited and will be available on a firstcome, first-served basis.
Instructions: You are free to submit
comments at any time, including orally
at the teleconference as time permits,
but if you want Committee members to
review your comments before the
teleconference, please submit your
comments no later than October 14,
2021. We are particularly interested in
comments on the issues in the
‘‘Agenda’’ section below. We encourage
you to submit comments through the
Federal eRulemaking Portal at https://
www.regulations.gov. If your material
cannot be submitted using https://
www.regulations.gov, call or email the
individual in the FOR FURTHER
INFORMATION CONTACT section of this
document for alternate instructions. You
must include the docket number
[USCG–2010–0164]. Comments received
will be posted without alteration at
https://www.regulations.gov, including
any personal information provided. You
may wish to view the Privacy and
Security notice available on the
homepage of https://regulations.gov and
DHS’s eRulemaking System of Records
notice (85 FR 14226, March 11, 2020).
If you encounter technical difficulties
with comment submission, contact the
individual listed in the FOR FURTHER
INFORMATION CONTACT section of this
notice.
Docket Search: Documents mentioned
in this notice as being available in the
docket, and all public comments, will
be in our online docket at https://
www.regulations.gov and can be viewed
by following that website’s instructions.
Additionally, if you go to the online
docket and sign-up for email alerts, you
will be notified when comments are
posted.
FOR FURTHER INFORMATION CONTACT: Mr.
Jeff Decker, Alternate Designated
Federal Officer of the National Boating
Safety Advisory Committee, 2703
Martin Luther King Jr. Ave. SE, Stop
7509, Washington, DC 20593–7509,
telephone 202–372–1507 or NBSAC@
uscg.mil.
SUPPLEMENTARY INFORMATION: Notice of
this meeting is given pursuant to the
Federal Advisory Committee Act, (5,
U.S.C. Appendix). The National Boating
Safety Advisory Committee was
established on December 4, 2018, by
§ 601 of the Frank LoBiondo Coast
Guard Authorization Act of 2018 (Pub.
L. 115–282, 132 Stat. 4192). That
authority is codified in 46 U.S.C. 15105.
FURTHER INFORMATION CONTACT
E:\FR\FM\29SEN1.SGM
29SEN1
]]>Agencies
[Federal Register Volume 86, Number 186 (Wednesday, September 29, 2021)]
[Notices]
[Page 53972]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 2021-21133]
-----------------------------------------------------------------------
DEPARTMENT OF HEALTH AND HUMAN SERVICES
National Institutes of Health
National Institute of Allergy and Infectious Diseases; Notice of
Closed Meeting
Pursuant to section 10(d) of the Federal Advisory Committee Act, as
amended, notice is hereby given of the following meeting.
The meeting will be closed to the public in accordance with the
provisions set forth in sections 552b(c)(4) and 552b(c)(6), Title 5
U.S.C., as amended. The grant applications and the discussions could
disclose confidential trade secrets or commercial property such as
patentable material, and personal information concerning individuals
associated with the grant applications, the disclosure of which would
constitute a clearly unwarranted invasion of personal privacy.
Name of Committee: National Institute of Allergy and Infectious
Diseases Special Emphasis Panel; NIAID Investigator Initiated
Program Project Applications (P01 Clinical Trial Not Allowed).
Date: October 22, 2021.
Time: 11:00 a.m. to 5:00 p.m.
Agenda: To review and evaluate grant applications.
Place: National Institute of Allergy and Infectious Diseases,
National Institutes of Health, 5601 Fishers Lane, Room 3G56,
Rockville, MD 20892 (Virtual Meeting).
Contact Person: Poonam Tewary, Ph.D., Scientific Review Officer,
Scientific Review Program, Division of Extramural Activities,
National Institute of Allergy and Infectious Diseases, National
Institutes of Health, 5601 Fishers Lane, Room 3G56, Rockville, MD
20852, (301) 761-7219, [email protected].
(Catalogue of Federal Domestic Assistance Program Nos. 93.855,
Allergy, Immunology, and Transplantation Research; 93.856,
Microbiology and Infectious Diseases Research, National Institutes
of Health, HHS)
Dated: September 23, 2021.
Tyeshia M. Roberson-Curtis,
Program Analyst, Office of Federal Advisory Committee Policy.
[FR Doc. 2021-21133 Filed 9-28-21; 8:45 am]
BILLING CODE 4140-01-P
